COSUTI:成人非复杂性尿路感染治疗干预核心结局集开发方案
本文介绍COSUTI方案,旨在为成人非复杂性尿路感染治疗干预开发核心结局集(COS)。方案分三阶段:系统综述识别已报告结局,三轮在线德尔菲调查达成共识,共识会议最终确定COS。期望该COS成为该领域试验应报告和测量的最小结局集,以提高试验间结果可比性。
要点
- 非复杂性尿路感染治疗试验结局报告不一致,影响证据合成与比较。
- COSUTI通过系统综述、德尔菲调查和共识会议三阶段开发核心结局集。
- 核心结局集旨在作为该领域临床试验应报告和测量的最小结局集合。
核心结论
- 期望开发的核心结局集被采纳为成人非复杂性尿路感染治疗干预试验应报告和测量的最小结局集。
研究设计与样本
- 方案包括三阶段:第一阶段为系统综述,识别成人非复杂性尿路感染治疗干预试验和系统综述中报告的结局。
- 第二阶段为三轮在线德尔菲调查,纳入尿路感染治疗干预领域的利益相关者,就第一阶段产生的结局重要性达成共识。
- 第三阶段为共识会议,最终确定评估尿路感染治疗干预有效性的试验应报告的核心结局集。
临床怎么用
- 若相关临床试验结果要影响政策和实践,不同治疗干预的试验结果需具有可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Urinary tract infections (UTIs) are the second most common infection presenting in the community. Clinical guidelines and decision aids assist health practitioners to treat a UTI; however, treatment practices vary due to patient needs and context of presentation. Numerous trials have evaluated the effectiveness of treatment interventions for UTI; however, it is difficult to compare the results between trials due to inconsistencies between reported outcomes. Poor choice of outcome measures can lead to impairment of evidence synthesis due to the inability to compare outcomes between trials with similar aims. Transparency in selecting and reporting outcomes can be mitigated through the development of an agreed minimum set of outcomes that should be reported in clinical trials, referred to as a core outcome set (COS). This paper presents the protocol for the development of a COS for interventions in the treatment of uncomplicated UTI in adults. METHODS: This COS development consists of three phases. Phase 1 is a systematic review, which aims to identify the core outcomes that have been reported in trials and systematic reviews of interventions treating uncomplicated UTI in adults. Phase 2 consists of a three-round online Delphi survey with stakeholders in the area of treatment interventions for UTI. The aim of this online Delphi survey is to achieve consensus on the importance of the outcomes emerging from Phase 1 of this research. Phase 3 is a consensus meeting to finalise the COS that should be reported in trials evaluating the effectiveness of interventions for the treatment of UTI. DISCUSSION: It is hoped that the development of a COS for interventions for the treatment of uncomplicated UTI in adults will be adopted as a minimum set of outcomes that should be reported and measured within this context. If the findings from clinical trials related to treatment interventions for UTI are to impact on policy and practice, it is important that the findings from different treatment interventions are comparable across trials.
引用
- Duane S, Vellinga A, Murphy AW, et al. COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults. Trials. 2019. PMID: 30732617. doi:10.1186/s13063-019-3194-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。